amifostine anhydrous has been researched along with Pharyngeal Neoplasms in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Pharyngeal Neoplasms: Tumors or cancer of the PHARYNX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Büntzel, J | 1 |
| Glatzel, M | 1 |
| Kuttner, K | 1 |
| Weinaug, R | 1 |
| Fröhlich, D | 1 |
1 trial available for amifostine anhydrous and Pharyngeal Neoplasms
| Article | Year |
|---|---|
Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amifostine; Carboplatin; Carcinoma, Squamous Cell; Combi | 2002 |